AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32709172 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided Erector Spinae Plane (ESP) block
Number of subjects: 48
Study 32709172 — intervention group
Group type: COMPARATOR
Intervention: Bilateral ultrasound-guided Transversus Abdominis Plane (TAP) block
Number of subjects: 48
Study 616681315 — intervention group
Group type: EXPERIMENTAL
Intervention: 7‐d PUFA‐rich diet
Number of subjects: 26
Study 616681315 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 26
Study 34817667 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication reconciliation at hospital admission
Number of subjects: 120
Study 34817667 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 120
Study 33486475 — intervention group
Group type: EXPERIMENTAL
Intervention: IVC ultrasonography-guided hydration
Number of subjects: 207
Study 33486475 — intervention group
Group type: COMPARATOR
Intervention: Standard hydration (0.9% saline at 0.5 mL/(kg·h))
Number of subjects: 207
Study 32105310 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin (FC) <250 µg/g
Number of subjects: 0
Study 32105310 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP <5 mg/L
Number of subjects: 0
Study 32105310 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin <250 µg/g, CRP <5 mg/L, and CDAI <150
Number of subjects: 0
Study 33651728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (BIC)
Number of subjects: 8
Study 33651728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study 32236400 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAM‐V Program
Number of subjects: 77
Study 32236400 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study 35313276 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery™ (ER)
Number of subjects: 25
Study 35313276 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25
Study 35313276 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of N3-rich foods and supplement compliance
Number of subjects: 25
Study 32014809 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week CBT-I program
Number of subjects: 33
Study 32014809 — intervention group
Group type: COMPARATOR
Intervention: 6-week active control
Number of subjects: 33
Study 32014809 — intervention group
Group type: COMPARATOR
Intervention: Single session of sleep education
Number of subjects: 33
Study 33814320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high-flow therapy (NHFT)
Number of subjects: 23
Study 33046533 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-base pair core-enclosing helix (CEH)
Number of subjects: 1157
Study 33046533 — intervention group
Group type: COMPARATOR
Intervention: ΔCEH, 1-bp, and 2-bp alleles
Number of subjects: 1157
Study 33046533 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-bp CEH RNA
Number of subjects: 1157
Study 33046533 — intervention group
Group type: COMPARATOR
Intervention: Shorter-CEH constructs
Number of subjects: 1157
Study 35135495 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid learning method (distance learning and small group peer-to-peer simulation training sessions with remote supervision)
Number of subjects: 100
Study 35135495 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid learning method
Number of subjects: 100
Study 35135495 — intervention group
Group type: COMPARATOR
Intervention: Conventional simulation learning (lectures and classic simulation-based training)
Number of subjects: 100
Study 35135495 — intervention group
Group type: COMPARATOR
Intervention: Conventional simulation learning
Number of subjects: 100
Study 34298005 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal household air pollution exposure (measured by carbon monoxide, CO)
Number of subjects: 1414
Study 34298005 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal household air pollution exposure (measured by carbon monoxide, CO)
Number of subjects: 1414
Study 32357107 — intervention group
Group type: EXPERIMENTAL
Intervention: SDLMI + Whose Future Is It? (SDLMI + WF)
Number of subjects: 0
Study 32357107 — intervention group
Group type: COMPARATOR
Intervention: Self‐Determined Learning Model of Instruction (SDLMI) only
Number of subjects: 0
Study 35840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative shared care follow-up with GPs (supported by online outcome monitoring) for 6 months
Number of subjects: 0
Study 35840297 — intervention group
Group type: COMPARATOR
Intervention: Self-directed screening and education about post-intensive care syndrome and child development
Number of subjects: 0
Study 35840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative shared care follow-up with GPs
Number of subjects: 0
Study 35840297 — intervention group
Group type: COMPARATOR
Intervention: Self-directed screening and education
Number of subjects: 0
Study 34551998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD‐MTX) 15-20 mg/week
Number of subjects: 4786
Study 34551998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4786
Study 34551998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD‐MTX)
Number of subjects: 4786
Study 34729823 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation with Mental Imagery (BA‐MI)
Number of subjects: 41
Study 34729823 — intervention group
Group type: COMPARATOR
Intervention: Attention‐Assessment control
Number of subjects: 41
Study 32565333 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg taken 1 hour before treatment
Number of subjects: 34
Study 32565333 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonibuprofen (no analgesics taken before treatment)
Number of subjects: 34
Study 32565333 — intervention group
Group type: COMPARATOR
Intervention: Control group (4 patients undergoing endodontic therapy for prosthodontic reasons, no analgesics)
Number of subjects: 34
Study 35586674 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion instrument combined with ultrashort wave
Number of subjects: 84
Study 35586674 — intervention group
Group type: COMPARATOR
Intervention: Moxibustion instrument
Number of subjects: 84
Study 33314332 — intervention group
Group type: EXPERIMENTAL
Intervention: Microtextured implants with a 3.6mm-long internal-connection machined collar
Number of subjects: 22
Study 33314332 — intervention group
Group type: COMPARATOR
Intervention: Machined implants with a 1.2mm-long external-connection machined collar
Number of subjects: 22
Study 33314332 — intervention group
Group type: COMPARATOR
Intervention: Microtextured implants with a 1.2mm-long external-connection machined collar
Number of subjects: 22
Study 33314332 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal-connection microtextured implants
Number of subjects: 22
Study 33314332 — intervention group
Group type: COMPARATOR
Intervention: External-connection microtextured implants
Number of subjects: 22
Study 33314332 — intervention group
Group type: EXPERIMENTAL
Intervention: All implant types
Number of subjects: 22
Study 32381373 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (14 mg)
Number of subjects: 20
Study 32381373 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 20
Study 32662323 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based guided self-help
Number of subjects: 100
Study 32662323 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 100
Study 35251396 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS group
Number of subjects: 60
Study 35251396 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment group
Number of subjects: 60
Study 33275152 — intervention group
Group type: EXPERIMENTAL
Intervention: DKA episodes with AKI
Number of subjects: 1359
Study 33275152 — intervention group
Group type: COMPARATOR
Intervention: DKA episodes without AKI
Number of subjects: 1359
Study 36264177 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra‐uterine foley's catheter
Number of subjects: 60
Study 36264177 — intervention group
Group type: COMPARATOR
Intervention: Leich‐Wilkinson cannula
Number of subjects: 60
Study 33293295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamas (community health volunteer-led, group-based health education programme)
Number of subjects: 1920
Study 33293295 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (monthly, individual CHV home visits)
Number of subjects: 1920
Study 35191654 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-energy rESWT (mrESWT)
Number of subjects: 39
Study 35191654 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy rESWT (hrESWT)
Number of subjects: 39
Study 34384821 — intervention group
Group type: EXPERIMENTAL
Intervention: ECPR
Number of subjects: 308
Study 34384821 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Resuscitation
Number of subjects: 308
Study 32214373 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized metabolism-informed care (MIC)
Number of subjects: 32
Study 32214373 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study 32214373 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 32
Study 35596182 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib as maintenance therapy
Number of subjects: 639
Study 35596182 — intervention group
Group type: COMPARATOR
Intervention: Newly derived reference values for treatment-naïve mPC patients
Number of subjects: 639
Study 34530495 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual reminiscence therapy for 8 weeks during home visits (once a week)
Number of subjects: 65
Study 34530495 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 65
Study 34530495 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 65
Study 33328172 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced services
Number of subjects: 0
Study 33328172 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 32067533 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose folic acid (4.0-5.1 mg daily)
Number of subjects: 428
Study 32067533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study 34628865 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention program
Number of subjects: 159
Study 34628865 — intervention group
Group type: COMPARATOR
Intervention: Conventional intervention
Number of subjects: 159
Study 32442195 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-primed regimen
Number of subjects: 242
Study 32442195 — intervention group
Group type: COMPARATOR
Intervention: ALVAC-primed regimen
Number of subjects: 242
Study 32442195 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-primed regimen via Biojector
Number of subjects: 242
Study 35410783 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 sachet of macrogol a day, one week prior to surgery
Number of subjects: 82
Study 35410783 — intervention group
Group type: COMPARATOR
Intervention: No preoperative laxatives
Number of subjects: 82
Study 33663414 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent Training (MT) biweekly exercise sessions for 6 months
Number of subjects: 0
Study 33663414 — intervention group
Group type: COMPARATOR
Intervention: Monthly sessions regarding physical activity and health-related topics for 6 months (Control)
Number of subjects: 0
Study 33663414 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent Training (MT)
Number of subjects: 0
Study 34716884 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Pilates exercises conducted 3 days a week for 6 weeks, 1 hour a day.
Number of subjects: 33
Study 34716884 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise program).
Number of subjects: 33
Study 34124256 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV
Number of subjects: 360
Study 34124256 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV
Number of subjects: 360
Study 34124256 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV
Number of subjects: 360
Study 34124256 — intervention group
Group type: EXPERIMENTAL
Intervention: T. pallidum
Number of subjects: 360
Study 34124256 — intervention group
Group type: EXPERIMENTAL
Intervention: Any STI
Number of subjects: 360
Study 35379537 — intervention group
Group type: EXPERIMENTAL
Intervention: Case Management with Problem-Solving Therapy (CM-PST)
Number of subjects: 56
Study 33846747 — intervention group
Group type: EXPERIMENTAL
Intervention: Aneuploid embryos (n=20)
Number of subjects: 30
Study 33846747 — intervention group
Group type: COMPARATOR
Intervention: Euploid embryos (n=10)
Number of subjects: 30
Study 33846747 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age
Number of subjects: 30
Study 35579583 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride-releasing sealant (Helioseal® F)
Number of subjects: 44
Study 35579583 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish (Duraphat®)
Number of subjects: 44
Study 33276125 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD use
Number of subjects: 1350
Study 33276125 — intervention group
Group type: COMPARATOR
Intervention: No IUD use (otherwise)
Number of subjects: 1350
Study 33276125 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple partners at baseline
Number of subjects: 1350
Study 32171064 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance budesonide (200 μg twice per day) plus as-needed salbutamol (two inhalations of 100 μg)
Number of subjects: 675
Study 32171064 — intervention group
Group type: COMPARATOR
Intervention: As-needed salbutamol (two inhalations of 100 μg)
Number of subjects: 675
Study 32171064 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol (one inhalation of 200 μg budesonide and 6μg formoterol)
Number of subjects: 675
Study 35074887 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-administered recovery programme (3 sessions, 2 weeks apart)
Number of subjects: 207
Study 35074887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 207
Study 32650047 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial difficulty
Number of subjects: 451
Study 32650047 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple hardships
Number of subjects: 451
Study 32650047 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing disrepair
Number of subjects: 451
Study 32650047 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal sleep practices
Number of subjects: 451
Study 32650047 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal sleep practices in infancy
Number of subjects: 451
Study 34261997 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial wrist‐worn activity tracker (Polar Loop 2; Polar, Kempele, Finland) worn for 12 months
Number of subjects: 231
Study 34261997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 231
Study 34312316 — intervention group
Group type: EXPERIMENTAL
Intervention: TERECO (telerehabilitation programme)
Number of subjects: 120
Study 34312316 — intervention group
Group type: COMPARATOR
Intervention: Control (no rehabilitation)
Number of subjects: 120
Study 33038833 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (50 mg/Kg/day)
Number of subjects: 96
Study 33038833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 33038833 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 96
Study 32871950 — intervention group
Group type: EXPERIMENTAL
Intervention: Conbercept 6-monthly loading dose injection and PRN (6+PRN)
Number of subjects: 0
Study 32871950 — intervention group
Group type: COMPARATOR
Intervention: Conbercept 3-monthly loading dose injection and PRN (3+PRN)
Number of subjects: 0
Study 36031597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy
Number of subjects: 122
Study 32064906 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic tests
Number of subjects: 13
Study 32064906 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic tests supported by randomized controlled trials
Number of subjects: 13
Study 35502861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Acclimation (CA) - immersion to the chest in 14°C water for ≥120 min daily over a 5-day period
Number of subjects: 14
Study 35502861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Acclimation (CA)
Number of subjects: 14
Study 35502861 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) - instructed to avoid any cold exposure during the 5-day period
Number of subjects: 14
Study 34391917 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (L group)
Number of subjects: 24
Study 34391917 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D group)
Number of subjects: 24
Study 34391917 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine-Dexmedetomidine (LD group)
Number of subjects: 24
Study 34391917 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study 35460249 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) supplementation (weekly 50,000 IU for 4 weeks followed by daily 2000 IU until 1 year)
Number of subjects: 4000
Study 35460249 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) supplementation
Number of subjects: 4000
Study 35460249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4000
Study 33763741 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous local anaesthetic wound infusion
Number of subjects: 38
Study 33763741 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia
Number of subjects: 38
Study 32198802 — intervention group
Group type: EXPERIMENTAL
Intervention: IRL752
Number of subjects: 32
Study 32198802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 36069038 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectation instructional set during pain-inducing massage
Number of subjects: 56
Study 36069038 — intervention group
Group type: COMPARATOR
Intervention: Negative expectation instructional set during pain-inducing massage
Number of subjects: 56
Study 36069038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-free massage with positive expectation
Number of subjects: 56
Study 36069038 — intervention group
Group type: COMPARATOR
Intervention: Pain-free massage with negative expectation
Number of subjects: 56
Study 32633172 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professionals (speech and language therapists, neurologists)
Number of subjects: 10
Study 32633172 — intervention group
Group type: COMPARATOR
Intervention: Naïve listeners (general population, PD relatives, PD patients)
Number of subjects: 10
Study 32056444 — intervention group
Group type: EXPERIMENTAL
Intervention: No protocol (rounds 1;2)
Number of subjects: 155
Study 32056444 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A (rounds 3;4)
Number of subjects: 155
Study 32056444 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (rounds 3;4)
Number of subjects: 155
Study 32056444 — intervention group
Group type: EXPERIMENTAL
Intervention: No protocol to Protocol B (urologists)
Number of subjects: 155
Study 33776935 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing + Standard Education (MI+SE)
Number of subjects: 47
Study 33776935 — intervention group
Group type: COMPARATOR
Intervention: Standard Education (SE) only
Number of subjects: 47
Study 32144911 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint thread-embedding therapy at 7-day intervals (Treatment Group 1)
Number of subjects: 70
Study 32144911 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint thread-embedding therapy at 14-day intervals (Treatment Group 2)
Number of subjects: 70
Study 32144911 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Treatment Group 1 and Treatment Group 2
Number of subjects: 70
Study 34384793 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐MAC
Number of subjects: 50
Study 34384793 — intervention group
Group type: COMPARATOR
Intervention: Airtraq
Number of subjects: 50
Study 34843437 — intervention group
Group type: EXPERIMENTAL
Intervention: WISE COACH (WC) video
Number of subjects: 1200
Study 34843437 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 1200
Study 34329456 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational therapy program (3 sessions a week for 2 weeks)
Number of subjects: 58
Study 34329456 — intervention group
Group type: COMPARATOR
Intervention: Routine daily activities
Number of subjects: 58
Study 34207484 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-Glycerylphosphorylcholine (αGPC)
Number of subjects: 39
Study 34207484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 32096282 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked continuous glucose monitoring for up to 14 days
Number of subjects: 143
Study 32096282 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked continuous glucose monitoring
Number of subjects: 143
Study 32096282 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring metrics
Number of subjects: 143
Study 35634828 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise intervention (12 weeks, 2 days/week, 50-minute sessions)
Number of subjects: 67
Study 35634828 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study 33021118 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling sessions with fidelity monitoring using audio recordings
Number of subjects: 1238
Study 33021118 — intervention group
Group type: COMPARATOR
Intervention: Counseling sessions without fidelity monitoring (implied control)
Number of subjects: 1238
Study 34725668 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking group (n=31)
Number of subjects: 168
Study 34725668 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal interaction group (n=31)
Number of subjects: 168
Study 34725668 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual control group (n=29)
Number of subjects: 168
Study 34547450 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 113
Study 34547450 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (MT)
Number of subjects: 113